Program Description
We are pleased to announce "The Aspen Course" will be returning to an in-person format in 2022.
The Aspen Course is a unique opportunity for those early career movement disorders specialists, in particular Movement Disorders Fellows, to advance their knowledge and evaluate their careers through advice from advanced professionals in the field.The course program will discuss the classification of these disorders, their differential diagnosis, and their treatment. The course curriculum also covers the phenomenology, pathophysiology, pathogenesis, epidemiology, genetics, and other aspects of the entire field of Movement Disorders... By registering for this course, you agree to the statement provided in the section below labeled 'Assumption of Risk and Liability - COVID'.
Topics
- Hyperkinetic Movement Disorders
- Non-motor Symptoms/Disorders
- Other Movement Disorders
- Parkinson Disease/Hypokinetic Movement Disorders
- Therapies-Pharmacological
- Therapies-Surgical
Faculty
Course Directors
Michael Okun, MD - University of Florida Fixel Institute for Neurological Diseases, Gainesville, FL, USA
Cynthia Comella, MD, FAAN, FASM, FANA - Rush University Medical Center, Chicago, IL, USA
Faculty
Alberto Espay, MD, MSc - University of Cincinnati, Cincinnati, OH, USA
Susan Fox, MRCP(UK), PhD - University of Toronto, Toronto, ON, Canada
Jennifer Goldman, MD, MS - Shirley Ryan AbilityLab and Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Mark Hallett, MD - NINDS, Bethesda, MD, USA
Joseph Jankovic, MD - Baylor College of Medicine, Houston, TX, USA
Course Purpose
This material will be presented utilizing didactic lectures and clinical discussion; along with case presentations, video demonstrations and panel discussions.
This course provides a comprehensive overview of an extensive variety of different movement disorders. The most effective and efficient manner to communicate this abundance of information is through didactic lecture with question and discussion time. Many of the lectures include video case presentations to visually demonstrate characteristics and other physical symptoms of the various hyperkinetic and hypokinetic movement disorders. In addition, case examples are also discussed to provide examples of the various disorders as observed in clinical practice.
The Comprehensive Review of Movement Disorders for the Clinical Practitioner course is the highly successful program originally accredited for CME by Columbia University until transferred to MDS in 2016. The program provides a robust scientific content and interaction with the leaders and innovators of the movement disorders field
The tradition of the Aspen Course
"As a rite of passage every movement disorder fellow must pass through the Aspen course."
The legend of the Aspen course
"Anyone serious about movement disorders has taken the Aspen course at least once."
Registration Fees
Members: $625 USD
Members: Junior / HP / Basic Science / No Fee: $375 USD
Non-Members: $750 USD
To view the course schedule, please click 'PROCEED TO COURSE'.
Learning Objectives
1. Recognize and classify parkinsonism, tremor, and other movement disorders
2. Differentiate atypical parkinsonism from Parkinson’s disease
3. Appraise treatment approaches for parkinsonism, dystonia, tremor, chorea, and other movement disorders
4. Evaluate the phenomenology and classification of functional (psychogenic) disorders
5. Formulate and classify gait disorders in parkinsonism, ataxia, and other hypokinetic or hyperkinetic movement disorders
Intended Audience
This course is intended for general neurologists, neurology residents, Movement Disorders fellows, and other health professionals who wish to enhance their knowledge of Movement Disorders.
Accreditation Credit
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The International Parkinson and Movement Disorder Society designates this activity for a maximum of 27.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.
Method of Participation
Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.
Faculty Disclosure
All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.
Cynthia Comella: Speaker, Planner
Nothing to Disclose
Alberto Espay:Speaker
Nothing to Disclose
Susan Fox:Speaker
Speaker: Bial, Paladin
Consultant: Alexion, Bial, Merk, Pharma 2B, Sunovion, Teva, Paladin
Jennifer Goldman: Speaker
Grant: Acadia
Mark Hallett:Speaker
Grant: Medtronic
Royalty: Brainsway
Joseph Jankovic: Speaker
Nothing to Disclose
Michael Okun: Speaker, Planner
Nothing to Disclose
Ravi Yadav: Reviewer
Nothing to Disclose
Rafael Zuzuarregui: Reviewer
Nothing to Disclose
Staff Disclosure
MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
Sponsor Information
The Comprehensive Review of Movement Disorders for the Clinical Practitioner course is supported in part by educational grants from:
The Parkinson's Foundation
The PMD Alliance
Funding Statement
The Comprehensive Review of Movement Disorders for the Clinical Practitioner course has received unrestricted medical education grants from the following:
AbbVie Inc.
Boston Scientific Corporation
GE Healthcare Inc.
Kyowa Kirin, Inc.
Merz Pharmaceuticals, LLC
Sunovion Pharmaceuticals Inc.
Supporter Statement
The Comprehensive Review of Movement Disorders for the Clinical Practitioner course wishes to acknowledge the following commercial supporters and exhibitors:
AbbVie, Inc.
Acadia Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc.
Cala Health
Kyowa Kirin, Inc.
Merz North America, Inc.
Supernus Pharmaceuticals, Inc.
Registration Cancellation Policy
Registration may be cancelled up until 2 weeks before the course, minus a $25 USD cancellation fee. After this time, the registration fee is nonrefundable.
MDS Secretariat Liaison
Kate Rudolph